’s Baupost Group, one of the largest hedge funds in the world, reported in a new filing with the SEC increasing its exposure at Idenix Pharmaceuticals Inc (NASDAQ:IDIX
) to 36.9 million shares, from 26.8 million in its latest 13F. The upgraded stake amasses almost 27.6% of the company.
Peter Kolchinsky’s RA Capital Boosts Stake in Achillion to 21.2%
Paul Singer’s Elliott Management Reports a 2.9% Stake in National Bank Holdings
Billionaire Ron Burkle Wants To Buy Morgans Hotel Group